Article info
PDFLiver
Original research
Faecal calprotectin is a surrogate marker of biliary inflammation in primary sclerosing cholangitis associated inflammatory bowel disease
- Correspondence to Dr Polychronis Pavlidis, King's College London, London WC2R 2LS, UK; polychronis.pavlidis{at}kcl.ac.uk; Dr Nick Powell; nicholas.powell{at}imperial.ac.uk
Citation
Faecal calprotectin is a surrogate marker of biliary inflammation in primary sclerosing cholangitis associated inflammatory bowel disease
Publication history
- Received November 12, 2021
- Accepted March 4, 2022
- First published March 18, 2022.
Online issue publication
January 23, 2024
Article Versions
- Previous version (7 October 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.